Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Healthcare Medical Devices Diagnostics & Research
Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence... see more

Recent & Breaking News (CSE:IME)

Canadian Investment Regulatory Organization Trading Halt - IME

Canada NewsWire February 5, 2024

Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in(TM) and No-Pass Mimic(TM) Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin

PR Newswire July 25, 2022

Imagin Medical Announces Stock Option Grants

PR Newswire April 22, 2022

Imagin Medical Announces Appointment of Kayvon Namvar to Board of Directors and Kevin Slawin, M.D. as Board Chairman

PR Newswire November 8, 2021

Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.

PR Newswire August 30, 2021

Imagin Medical Secures New $3 Million Convertible Note Financing

GlobeNewswire August 26, 2021

Imagin Medical on Schedule for American Urology Association Demonstration

GlobeNewswire August 17, 2021

IMAGIN MEDICAL REPORTS COMPANY ON SCHEDULE FOR PRODUCT DEMONSTRATION

GlobeNewswire May 19, 2021

IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS

GlobeNewswire March 16, 2021

IMAGIN MEDICAL CLOSES SECOND TRANCHE OF CONVERTIBLE NOTE OFFERING

GlobeNewswire February 18, 2021

Imagin Medical Engages Torrey Hills Capital

GlobeNewswire January 20, 2021

InvestorBrandNetwork (IBN) Coverage Initiated for Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)

GlobeNewswire January 13, 2021

Imagin Medical Builds Momentum for 2021

GlobeNewswire January 13, 2021

Imagin Medical Closes First Tranche of Convertible Notes Offering

Accesswire November 10, 2020

Imagin Medical Announces Agenda for KOL Virtual Investor Event on October 29, 2020

Accesswire October 26, 2020

CSE Bulletin: Consolidation - Imagin Medical Inc. (IME)

Newsfile October 26, 2020

IIROC Trade Resumption - IME

Canada NewsWire October 22, 2020

Imagin Medical Announces Proposed Offering of $3 Million of Convertible Notes and Share Consolidation

Accesswire October 22, 2020

IIROC Trading Halt - IME

Canada NewsWire October 22, 2020

Establishing a New Standard in Surgical Imaging

Featured Submission October 19, 2020